The role of functional data in interpreting the effects of genetic variation

Molecular Biology of the Cell

Volumn 26, Issue 22, 2015, Pages 3904-3908

  Young, David L ^a   Fields, Stanley ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPISTASIS; GENE INTERACTION; GENE MUTATION; GENETIC DISORDER; GENETIC VARIABILITY; GENOTYPE; HIGH THROUGHPUT SEQUENCING; HUMAN; MALIGNANT NEOPLASTIC DISEASE; PHENOTYPE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; REVIEW; DNA SEQUENCE; GENETIC VARIATION; MUTATION; PROCEDURES; STATISTICAL ANALYSIS;

DATA INTERPRETATION, STATISTICAL; GENETIC VARIATION; HUMANS; MUTATION; SEQUENCE ANALYSIS, DNA;

EID: 84946782251     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E15-03-0153     Document Type: Review

References (48)

1. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR (2010). A method and server for predicting damaging missense mutations. Nat Methods 7, 248-249.
2. Agarwala V, Flannick J, Sunyaev S, GoT2D Consortium, Altshuler D (2013). Evaluating empirical bounds on complex disease genetic architecture. Nat Genet 45, 1418-1427.
3. Araya CL, Fowler DM, Chen W, Muniez I, Kelly JW, Fields S (2012). A fundamental protein property, thermodynamic stability, revealed solely from large-scale measurements of protein function. Proc Natl Acad Sci USA 109, 16858-16863.
4. Besenbacher S, Liu S, Izarzugaza JMG, Grove J, Belling K, Bork-Jensen J, Huang S, Als TD, Li S, Yadav R, et al. (2015). Novel variation and de novo mutation rates in population-wide de novo assembled Danish trios. Nat Commun 6, 5969.
5. Cancer Genome Atlas Research Network (2013). Integrated genomic characterization of endometrial carcinoma. Nature 497, 67-73.
6. Chari S, Dworkin I (2013). The conditional nature of genetic interactions: the consequences of wild-type backgrounds on mutational interactions in a genome-wide modifer screen. PLoS Genet 9, e1003661.
7. Chatterjee N, Wheeler B, Sampson J, Hartge P, Chanock SJ, Park J-H (2013). Projecting the performance of risk prediction based on polygenic analyses of genome-wide association studies. Nat Genet 45, 400-405.
8. Costanzo M, Baryshnikova A, Bellay J, Kim Y, Spear ED, Sevier CS, Ding H, Koh JLY, Toufghi K, Mostafavi S, et al. (2010). The genetic landscape of a cell. Science 327, 425-431.
9. Dong C, Wei P, Jian X, Gibbs R, Boerwinkle E, Wang K, Liu X (2015). Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies. Hum Mol Genet 24, 2125-2137.
10. Exome Aggregation Consortium (2015). ExAC Browser, Cambridge, MA. http://exac.broadinstitute.org (accessed 25 May 2015).
11. Fowler DM, Araya CL, Gerard W, Fields S (2011). Enrich: software for analysis of protein function by enrichment and depletion of variants. Bioinformatics 27, 3430-3431.
12. Fowler DM, Fields S (2014). Deep mutational scanning: a new style of protein science. Nat Methods 8, 801-807.
13. Fu W, O'Connor TD, Jun G, Kang HM, Abecasis G, Leal SM, Gabriel S, Rieder MJ, Altshuler D, Shendure J, et al. (2013). Analysis of 6, 515 exomes reveals the recent origin of most human protein-coding variants. Nature 493, 216-220.
14. Gibson G (2012). Rare and common variants: twenty arguments. Nat Rev Genet 13, 135-145.
15. Grantham R (1974). Amino acid difference formula to help explain protein evolution. Science 185, 862-864.
16. Guy MP, Young DL, Payea MJ, Zhang X, Kon Y, Dean KM, Grayhack EJ, Mathews DH, Fields S, Phizicky EM (2014). Identifcation of the determinants of tRNA function and susceptibility to rapid tRNA decay by high-throughput in vivo analysis. Genes Dev 28, 1721-1732.
17. Hemani G, Shakhbazov K, Westra HJ, Esko T, Henders AK, McRae AF, Yang J, Gibson G, Martin NG, Metspalu A, et al. (2014). Detection and replication of epistasis infuencing transcription in humans. Nature 508, 249-253.
18. Henn BM, Botigué LR, Bustamante CD, Clark AG, Gravel S (2015). Estimating the mutation load in human genomes. Nat Rev Genet 16, 333-343.
19. Hill WG, Goddard ME, Visscher PM (2008). Data and theory point to mainly additive genetic variance for complex traits. PLoS Genet 4, e1000008.
20. Jerby-Arnon L, Pfetzer N, Waldman YY, McGarry L, James D, Shanks E, Seashore-Ludlow B, Weinstock A, Geiger T, Clemons PA, et al. (2014). Predicting cancer-specifc vulnerability via data-driven detection of synthetic lethality. Cell 158, 1199-1209.
21. Kircher M, Witten DM, Jain P, O'Roak BJ, Cooper GM, Shendure J (2014). A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet 46, 310-315.
22. Kong A, Frigge ML, Masson G, Besenbacher S, Sulem P, Magnusson G, Gudjonsson SA, Sigurdsson A, Jonasdottir A, Jonasdottir A, et al. (2012). Rate of de novo mutations and the importance of father's age to disease risk. Nature 488, 471-475.
23. Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM, Maglott DR (2014). ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res 42, D980-D985.
24. Li Q, Liu X, Gibbs RA, Boerwinkle E, Polychronakos C, Qu H-Q (2014). Gene-specifc function prediction for non-synonymous mutations in monogenic diabetes genes. PLoS One 9, e104452.
25. Martincorena I, Roshan A, Gerstung M, Ellis P, Van Loo P, McLaren S, Wedge DC, Fullam A, Alexandrov LB, Tubio JM, et al. (2015). High burden and pervasive positive selection of somatic mutations in normal human skin. Science 348, 880-886.
26. McLaughlin RN, Jr., Poelwijk FJ, Raman A, Gosal WS, Ranganathan R (2012). The spatial architecture of protein function and adaptation. Nature 491, 138-142.
27. McLendon R, Friedman A, Bigner D, Van Meir EG, Brat DJ, Mastrogianakis GM, Olson JJ, Mikkelsen T, Lehman N, Aldape K, et al. (2008). Comprehensive genomic characterization defnes human glioblastoma genes and core pathways. Nature 455, 1061-1068.
28. Millar EK, Graham PH, O'Toole SA, McNeil CM, Browne L, Morey AL, Eggleton S, Beretov J, Theocharous C, Capp A, et al. (2009). Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a fve-biomarker panel. J Clin Oncol 27, 4701-4708.
29. Moutsianas L, Agarwala V, Fuchsberger C, Flannick J, Rivas MA, Gaulton KJ, Albers PK, McVean G, Boehnke M, Altshuler D, et al. (2015). The power of gene-based rare variant methods to detect disease-associated variation and test hypotheses about complex disease. PLoS Genet 11, e1005165.
30. Navin N, Kendall J, Troge J, Andrews P, Rodgers L, McIndoo J, Cook K, Stepansky A, Levy D, Esposito D, et al. (2011). Tumour evolution inferred by single-cell sequencing. Nature 472, 90-94.
31. Ng PC, Henikoff S (2001). Predicting deleterious amino acid substitutions. Genome Res 11, 863-874.
32. Patwardhan RP, Lee C, Litvin O, Young DL, Pe'er D, Shendure J (2009). High-resolution analysis of DNA regulatory elements by synthetic saturation mutagenesis. Nat Biotechnol 27, 1173-1175.
33. Quang D, Chen Y, Xie X (2015). DANN: a deep learning approach for annotating the pathogenicity of genetic variants. Bioinformatics 31, 761-763.
34. Saeys Y, Inza I, Larrañaga P (2007). A review of feature selection techniques in bioinformatics. Bioinformatics 23, 2507-2517.
35. Starita LM, Young DL, Islam M, Kitzman JO, Gullingsrud J, Hause RJ, Fowler DM, Parvin JD, Shendure J, Fields S (2015). Massively parallel functional analysis of BRCA1 RING domain variants. Genetics 200, 413-422.
36. Stenson PD, Mort M, Ball EV, Shaw K, Phillips A, Cooper DN (2014). The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet 133, 1-9.
37. Stephan J, Stegle O, Beyer A (2015). A random forest approach to capture genetic effects in the presence of population structure. Nat Commun 6.
38. Stiffer MA, Hekstra DR, Ranganathan R (2015). Evolvability as a function of purifying selection in TEM-1 β-lactamase. Cell 160, 882-892.
39. Taylor MB, Ehrenreich IM (2014). Genetic interactions involving fve or more genes contribute to a complex trait in yeast. PLoS Genet 10, e1004324.
40. Tennessen JA, Bigham AW, O'Connor TD, Fu W, Kenny EE, Gravel S
41. McGee S, Do R, Liu X, Jun G, et al. (2012). Evolution and functional impact of rare coding variation from deep sequencing of human exomes. Science 337, 64-69.
42. Traina F, Visconte V, Elson P, Tabarroki A, Jankowska AM, Hasrouni E, Sugimoto Y, Szpurka H, Makishima H, O'Keefe CL, et al. (2014). Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms. Leukemia 28, 78-87.
43. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA, Kinzler KW (2013). Cancer genome landscapes. Science 339, 1546-1558.
44. Weigel MT, Dowsett M (2010). Current and emerging biomarkers in breast cancer: prognosis and prediction. Endocr Relat Cancer 17, R245-R262.
45. Weinreich DM, Lan Y, Wylie CS, Heckendorn RB (2013). Should evolutionary geneticists worry about higher-order epistasis? Curr Opin Genet Dev 23, 700-707.
46. Xiong HY, Alipanahi B, Lee LJ, Bretschneider H, Merico D, Yuen RKC, Hua Y, Gueroussov S, Najafabadi HS, Hughes TR, et al. (2015). The human splicing code reveals new insights into the genetic determinants of disease. Science 347, 1254806.
47. Yachida S, Jones S, Bozic I, Antal T, Leary R, Fu B, Kamiyama M, Hruban RH, Eshleman JR, Nowak MA, et al. (2010). Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467, 1114-1117.
48. Yang J, Lee SH, Goddard ME, Visscher PM (2011). GCTA: a tool for genome-wide complex trait analysis. Am J Hum Genet 88, 76-82.